A Study of JNJ-42847922 (Seltorexant) in Healthy Participants
Clinical trial NCT05236868 · COMPLETED
Trial details
- NCT number
- NCT05236868
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-03
- Primary completion
- 2022-03-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.